Return to homepagePandemic Pact

Application of recombinant bacterial membrane vesicles (BMVs) in vaccination against MERSCoV and H1N1 influenza virus.

  • Funded by Federal Ministry of Research, Technology and Space (BMFTR)
  • Total publications:0 publications

Grant number: HZI2021Z45

Grant search

Key facts

  • Disease

    Middle East respiratory syndrome coronavirus (MERS), Influenza caused by Influenza A virus subtype H1

  • Start & end year

    2021
    2022

  • Known Financial Commitments (USD)

    $51,240

  • Funder

    Federal Ministry of Research, Technology and Space (BMFTR)

  • Research Location

    Germany

  • Lead Research Institution

    Paul-Ehrlich-Institut Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract